What's happened
A body of studies is showing that a blood marker called p-tau217 can forecast an elevated risk of cognitive impairment in healthy older adults years before symptoms appear. The evidence is not yet clinical-ready, but it is guiding trials that aim to slow or prevent Alzheimer’s disease and is being tested in Scotland’s primary care setting.
What's behind the headline?
Writing strategy
- This is an update on biomarker research for Alzheimer’s.
- Maintain a concise, factual tone with clear transitions.
Key points
- p-tau217 in blood correlates with brain changes and may predict cognitive decline years ahead.
- Large-scale studies include healthy older adults; some data come from the US and UK pilots.
- The test is not yet routine for healthy individuals; it is primarily used to screen trial participants.
Implications
- If validated, the biomarker could streamline recruitment for prevention trials and accelerate early intervention strategies.
- Practical use will depend on further validation and ethical guidelines for testing.
How we got here
Researchers have long sought biomarkers to predict Alzheimer’s before symptoms. Recent trials and UK pilots are exploring p-tau217 in blood as a tool to identify high-risk individuals for prevention studies and early care planning.
Our analysis
Independent, SBS, New York Post, AP News, Bloomberg, Business Insider UK, and other outlets have reported on p-tau217 research and BriDGe Scotland pilots. Direct quotes include: Reisa Sperling cautions that the test is not yet for routine screening; Roche and UK researchers describe potential value for early diagnosis and trial enrollment.
Go deeper
- Will this blood test become part of routine health checks?
- How soon could trials using p-tau217 influence treatment options?
- What are the risks of testing healthy individuals for a disease biomarker?
More on these topics
-
London - Capital and largest city of England and the United Kingdom
London is the capital and largest city of both England and the United Kingdom, with a population of 9.1 million people in 2024. Its wider metropolitan area is the largest in Western Europe, with a population of 15.1 million. London stands on the River...
-
Associated Press - News agency company
The Associated Press is an American not-for-profit news agency headquartered in New York City. Founded in 1846, it operates as a cooperative, unincorporated association. Its members are U.S. newspapers and broadcasters.
-
Biogen - Biotechnology company
Biogen Inc. is an American multinational biotechnology company based in Cambridge, Massachusetts, specializing in the discovery, development, and delivery of therapies for the treatment of neurological diseases to patients worldwide.
-
Washington University in St. Louis - Private university in St. Louis, Missouri
Washington University in St. Louis is a private research university in Greater St. Louis with its main campus mostly in unincorporated St. Louis County, Missouri and Clayton, Missouri. It also has a West Campus in Clayton, North Campus in the West End nei
-
University of Pennsylvania - Private university in Philadelphia, Pennsylvania
The University of Pennsylvania is a private Ivy League research university in Philadelphia. The University claims a founding date of 1740 and is one of the nine colonial colleges chartered prior to the U.S. Declaration of Independence.
-
Mass General Brigham
Mass General Brigham is an integrated health system that includes 14 hospitals including Brigham and Women's Hospital and Massachusetts General Hospital, two of the nation's most prestigious teaching institutions. It was founded in 1994 with H.
-
Massachusetts - US State
Massachusetts, officially known as the Commonwealth of Massachusetts, is the most populous state in the New England region of the northeastern United States.
-
The Journal of the American Medical Association (JAMA) - Peer-reviewed journal
JAMA: The Journal of the American Medical Association is a peer-reviewed medical journal published 48 times a year by the American Medical Association. It publishes original research, reviews, and editorials covering all aspects of biomedicine. The journa
-
Robert Wood Johnson Foundation - Health care company
The Robert Wood Johnson Foundation is the United States' largest philanthropy focused solely on health; it is based in Princeton, New Jersey. The foundation's goal, through the use of grants, is "to improve the health and health care of all Americans." Th
-
Phoenix - City in Arizona
Phoenix is the capital and most populous city in Arizona, with 1,680,992 people. It is also the fifth most populous city in the United States along with being the largest state capital by population, and the only state capital with a population of more th
-
Howard Hughes Medical Institute - Foundation
The Howard Hughes Medical Institute (HHMI) is an American non-profit medical research organization based in Chevy Chase, Maryland. It was founded in 1953, by Howard Hughes who was an American business magnate, investor, record-setting pilot, engineer...
-
dementia - Long-term brain disorder causing personality changes and impaired memory, reasoning, and social function
Dementia is a syndrome, often associated with neurodegenerative diseases such as Alzheimer's, and characterized by a general decline in cognitive processes that affects the ability to perform everyday activities. This typically involves problems with memory, thinking, behavior, and motor control. Aside from memory impairment and a disruption in thought patterns, the most common symptoms of dementia include emotional problems, difficulties with language, and decreased motivation. The symptoms may be described as occurring in a continuum over several stages. Dementia is an incurable, progressive neurocognitive disorder, with varying degrees of severity (mild to major) and many forms or subtypes. The condition has a significant effect on the individual, their caregivers, and their social relationships in general. Dementia is not the same as age-related decline in cognition and memory, with no change in intelligence. The most common form of dementia is Alzheimer's. Dementia can be caused by brain injuries and stroke. It has also been described as a spectrum of disorders with subtypes of dementia based on which known disorder caused its development, such as Parkinson's disease for Parkinson...
-
University College London - Public university in London, England
University College London, officially known as UCL since 2005, is a public research university located in London, United Kingdom.
-
Tau - Protein
The tau proteins are a group of six highly soluble protein isoforms produced by alternative splicing from the gene MAPT. They have roles primarily in maintaining the stability of microtubules in axons and are abundant in the neurons of the central nervous
-
Massachusetts General Hospital - Teaching hospital in Boston, Massachusetts
Massachusetts General Hospital is the original and largest teaching hospital of Harvard Medical School located in the West End neighborhood of Boston, Massachusetts.
-
lecanemab - Medication
Lecanemab, sold under the brand name Leqembi, is a monoclonal antibody medication used for the treatment of Alzheimer's disease. Lecanemab is an amyloid beta-directed antibody. It is given via intravenous infusion to patients with mild cognitive impairmen
-
donanemab - Drug
Donanemab is a biological drug in trial to treat early symptoms of Alzheimer's disease. There is no cure or treatment for Alzheimer’s disease. Donanemab has shown positive results in Eli Lilly and Co.’s first two trials.